tradingkey.logo
tradingkey.logo
Search

J&J Receives Positive CHMP Opinion Of Nipocalimab To Treat Generalised Myasthenia Gravis (gMG)

ReutersSep 19, 2025 4:58 PM
facebooktwitterlinkedin

- Johnson & Johnson JNJ.N:

  • JOHNSON & JOHNSON RECEIVES POSITIVE CHMP OPINION OF NIPOCALIMAB TO TREAT A BROAD POPULATION OF ANTIBODY-POSITIVE PATIENTS LIVING WITH GENERALISED MYASTHENIA GRAVIS (GMG)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI